Lisa Su highlights judgment and problem-solving as critical amid surging demand for AI infrastructure and talent. Advanced Micro Devices CEO Lisa Su stated that technical knowledge alone will not suffice in the AI-driven economy. Speaking at MIT, she emphasized that purpos
Pfizer’s 6.58% yield contrasts with Merck’s 2.74%, as KEYTRUDA drives 12% revenue growth amid biosimilar risks. Pfizer reported a 6.58% dividend yield for 2025, distributing $9.8 billion at $1.72 per share, supported by $3.22 adjusted EPS. Non-COVID growth surged, with Abr
Breaking: US ISM Services PMI rises to 54.4 in May vs. 53.8 expected Business activity in the United States (US) service sector expanded at an accelerating pace in May, with the Institute for Supply Management's (ISM) Services Purchasing Managers' Index (PMI) rising to 54.5 from...</stron
The Healthcare Bridge Strategy a 62 Year Old Couple Used to Cover Five Years to Medicare on $42,000 a Year Quick Read - Keeping MAGI below $80,160 (400% of FPL) is critical because exceeding it by even $1 eliminates ACA subsidies entirely for a retiring couple. - Spending Roth...
Seeing your stocks appreciate is a great feeling because you can see you're making money, even if it's on paper for the time being. Making money regardless of how a stock price moves can be even better because you're not reliant on the sporadic nature of the market
Pivotal bioVenture Partners Investment Advisor increased its position in Trevi Therapeutics (NASDAQ:TRVI) during the first quarter, acquiring 296,944 shares in an estimated $3.32 million trade based on average quarterly pricing, according to a May 14, 2026, SEC filing. Wha
The ARK Space & Defense Innovation ETF (NYSEMKT:ARKX) offers actively managed exposure to disruptive space technologies, while the State Street SPDR S&P Aerospace & Defense ETF (NYSEMKT:XAR) provides low-cost, indexed-based access to established aerospace and defense companies.</
Seeking Alpha analyst Danil Sereda is turning bullish on PayPal (PYPL), citing excessive pessimism and attractive valuations, while Bay Area Ideas has upgraded JetBlue (JBLU) from Sell to Hold as bankruptcy concerns fade. On the downside, James Foord is Newsletters for Eve
Eli Lilly signed a collaboration and licensing agreement with Boston-based Ascidian Therapeutics on Wednesday to research and develop treatments for inherited kidney diseases, with Ascidian eligible to receive up to $1.9 billion under the deal. As part of the agreement, As
ING’s Padhraic Garvey and Michiel Tukker stress that Eurozone real rates are increasingly driven by structural forces such as fiscal expansion and record bond supply. They point to rising 10Y euro implied real rates since 2024, helped by German spending plans They w